10-K
Annual Report
SONOMA PHARMACEUTICALS, INC.
CIK: 1367083
File #: 001-33216
Balance Sheet
37 line items · 2 periods
XBRL
| Item | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 2,399,000 | 5,374,000 |
Accounts Receivable | 2,527,000 | 2,232,000 |
Inventory | 3,651,000 | 2,915,000 |
Other Non-Operating Current Assets | 3,436,000 | 1,915,000 |
Current portion of deferred consideration, net of discount | 87,000 | 212,000 |
Total current assets | 12,100,000 | 12,648,000 |
Property, Plant and Equipment | 310,000 | 225,000 |
Operating Lease Right-of-Use Asset | 602,000 | 84,000 |
Deferred Tax Assets, Non-Current | 884,000 | 589,000 |
Deferred consideration, net of discount, less current portion | 0 | 73,000 |
Other Non-Operating Non-Current Assets | 64,000 | 74,000 |
Total assets | 13,960,000 | 13,693,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 1,923,000 | 953,000 |
Accounts Payable | 2,252,000 | 2,224,000 |
Other Current Liabilities | 284,000 | 641,000 |
Short-Term Debt | 222,000 | 220,000 |
Operating Lease Liability, Current | 151,000 | 58,000 |
Total current liabilities | 4,832,000 | 4,096,000 |
Warranty and Other Provisions | 0 | 17,000 |
Withholding tax payable | 5,564,000 | 5,142,000 |
Operating Lease Liability, Non-Current | 469,000 | 27,000 |
Total liabilities | 10,865,000 | 9,282,000 |
Stockholders’ Equity: | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 0 | 0 |
Total Stockholders' Equity | 207,319,000 | 206,593,000 |
Total Stockholders' Equity | (200,981,000) | (197,806,000) |
Total Stockholders' Equity | (3,243,000) | (4,376,000) |
Total stockholders’ equity | 3,095,000 | 4,411,000 |
Additional Paid-in Capital | 207,319,000 | 206,593,000 |
Retained Earnings | (200,981,000) | (197,806,000) |
AOCI Attributable to Parent | (3,243,000) | (4,376,000) |
Total liabilities and stockholders’ equity | 13,960,000 | 13,693,000 |